Incubator

Home > DTx

DTx

Company Information
DTx creates novel RNA-based therapeutics to treat the genetic drivers of disease. Their proprietary delivery technology platform utilizes fatty acids as targeting ligands to enable the delivery of oligonucleotide therapies to tissues and cell types throughout the body. In preclinical studies, DTx has demonstrated cellular uptake and broad activity of oligonucleotides in the retina, muscle, heart, neurons, T cells and many other specialized cell types.


DTX.jpg